Literature DB >> 20835251

Allosteric potentiation of glycine receptor chloride currents by glutamate.

Jun Liu1, Dong Chuan Wu, Yu Tian Wang.   

Abstract

Neuronal excitability in the CNS is primarily controlled by a balance between synaptic excitation and inhibition. In the brainstem and spinal cord, synaptic excitation and inhibition are mediated by the excitatory transmitter glutamate acting on ionotropic glutamate receptor-gated cationic channels and the inhibitory transmitter glycine acting on glycine receptor (GlyR)-gated chloride channels. We found that glutamate and its analog ligands potentiated GlyR-mediated currents in both cultured spinal neurons and spinal cord slices of rats. This potentiation was not dependent on activation of any known glutamate receptor and manifested as an increase in single-channel open probability. Moreover, this glutamate potentiation was seen in HEK293 cells that transiently expressed GlyRs. Our data strongly suggest that glutamate allosterically potentiates GlyR-gated chloride channels, thereby blurring the traditional distinction between excitatory and inhibitory transmitters. Such a rapid homeostatic regulatory mechanism may be important for tuning functional balance between synaptic excitation and inhibition in the CNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20835251     DOI: 10.1038/nn.2633

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  36 in total

1.  A direct optimization approach to hidden Markov modeling for single channel kinetics.

Authors:  F Qin; A Auerbach; F Sachs
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

Review 2.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

Review 3.  Receptor trafficking and synaptic plasticity.

Authors:  Graham L Collingridge; John T R Isaac; Yu Tian Wang
Journal:  Nat Rev Neurosci       Date:  2004-12       Impact factor: 34.870

Review 4.  Extracellular level of GABA and Glu: in vivo microdialysis-HPLC measurements.

Authors:  Gabriella Nyitrai; Katalin A Kékesi; Gábor Juhász
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

Review 5.  Homeostatic signaling: the positive side of negative feedback.

Authors:  Gina Turrigiano
Journal:  Curr Opin Neurobiol       Date:  2007-04-23       Impact factor: 6.627

6.  The origin and neuronal function of in vivo nonsynaptic glutamate.

Authors:  David A Baker; Zheng-Xiong Xi; Hui Shen; Chad J Swanson; Peter W Kalivas
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

7.  N-methyl-D-aspartate enhancement of the glycine response in the rat sacral dorsal commissural neurons.

Authors:  T L Xu; X P Dong; D S Wang
Journal:  Eur J Neurosci       Date:  2000-05       Impact factor: 3.386

8.  GABAA responses in hippocampal neurons are potentiated by glutamate.

Authors:  A Stelzer; R K Wong
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

Review 9.  On the role of recurrent inhibitory feedback in motor control.

Authors:  U Windhorst
Journal:  Prog Neurobiol       Date:  1996-08       Impact factor: 11.685

10.  Ethanol suppresses fast potentiation of glycine currents by glutamate.

Authors:  Li Zhu; Kresimir Krnjević; Zhenghlin Jiang; Joseph J McArdle; Jiang Hong Ye
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

View more
  13 in total

Review 1.  Allosteric modulation of glycine receptors.

Authors:  Gonzalo E Yevenes; Hanns Ulrich Zeilhofer
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 2.  Glutamate-gated chloride channels.

Authors:  Adrian J Wolstenholme
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 3.  Inhibitory glycine receptors: an update.

Authors:  Sébastien Dutertre; Cord-Michael Becker; Heinrich Betz
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

4.  Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols.

Authors:  Cecilia M Borghese; Yuri A Blednov; Yu Quan; Sangeetha V Iyer; Wei Xiong; S John Mihic; Li Zhang; David M Lovinger; James R Trudell; Gregg E Homanics; R Adron Harris
Journal:  J Pharmacol Exp Ther       Date:  2011-10-28       Impact factor: 4.030

5.  Glycinergic Inhibitory Plasticity in Binaural Neurons Is Cumulative and Gated by Developmental Changes in Action Potential Backpropagation.

Authors:  Bradley D Winters; Nace L Golding
Journal:  Neuron       Date:  2018-03-22       Impact factor: 17.173

6.  A Missense Mutation A384P Associated with Human Hyperekplexia Reveals a Desensitization Site of Glycine Receptors.

Authors:  Chen-Hung Wang; Ciria C Hernandez; Junyi Wu; Ning Zhou; Hsin-Yu Hsu; Mei-Lin Shen; Yi-Ching Wang; Robert L Macdonald; Dong Chuan Wu
Journal:  J Neurosci       Date:  2018-02-13       Impact factor: 6.167

7.  The control of locomotor frequency by excitation and inhibition.

Authors:  Wen-Chang Li; Peter R Moult
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

8.  Clptm1 Limits Forward Trafficking of GABAA Receptors to Scale Inhibitory Synaptic Strength.

Authors:  Yuan Ge; Yunhee Kang; Robert M Cassidy; Kyung-Mee Moon; Renate Lewis; Rachel O L Wong; Leonard J Foster; Ann Marie Craig
Journal:  Neuron       Date:  2018-01-25       Impact factor: 17.173

9.  The GLRA1 missense mutation W170S associates lack of Zn2+ potentiation with human hyperekplexia.

Authors:  Ning Zhou; Chen-Hung Wang; Shu Zhang; Dong Chuan Wu
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

10.  Functional modulation of glycine receptors by the alkaloid gelsemine.

Authors:  Cesar O Lara; Pablo Murath; Braulio Muñoz; Ana M Marileo; Loreto San Martín; Victoria P San Martín; Carlos F Burgos; Trinidad A Mariqueo; Luis G Aguayo; Jorge Fuentealba; Patricio Godoy; Leonardo Guzman; Gonzalo E Yévenes
Journal:  Br J Pharmacol       Date:  2016-06-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.